3.7(top 10%)
impact factor
1.0K(top 20%)
papers
22.9K(top 10%)
citations
67(top 10%)
h-index
3.8(top 10%)
impact factor
1.2K
all documents
24.9K
doc citations
105(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulationTherapeutic Advances in Gastroenterology2013716
2Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organTherapeutic Advances in Gastroenterology2013642
3Fecal microbiota transplantation: in perspectiveTherapeutic Advances in Gastroenterology2016302
4Diagnosis and management of iron deficiency anemia in the 21st centuryTherapeutic Advances in Gastroenterology2011274
5Overutilization of proton-pump inhibitors: what the clinician needs to knowTherapeutic Advances in Gastroenterology2012255
6Pancreatic cancer: why is it so hard to treat?Therapeutic Advances in Gastroenterology2013250
7Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disordersTherapeutic Advances in Gastroenterology2012248
8Secondary causes of nonalcoholic fatty liver diseaseTherapeutic Advances in Gastroenterology2012205
9Use of probiotics in gastrointestinal disorders: what to recommend?Therapeutic Advances in Gastroenterology2010190
10The intestinal microbiota dysbiosis andClostridium difficileinfection: is there a relationship with inflammatory bowel disease?Therapeutic Advances in Gastroenterology2013182
11Fecal microbiota transplantation in relapsing Clostridium difficile infectionTherapeutic Advances in Gastroenterology2012173
12Current status of novel antifibrotic therapies in patients with chronic liver diseaseTherapeutic Advances in Gastroenterology2011171
13Immunogenicity of biologics in inflammatory bowel diseaseTherapeutic Advances in Gastroenterology2018168
14The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directionsTherapeutic Advances in Gastroenterology2016152
15Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infectionTherapeutic Advances in Gastroenterology2011149
16The role and utility of faecal markers in inflammatory bowel diseaseTherapeutic Advances in Gastroenterology2015140
17Advances in immunotherapy for colorectal cancer: a reviewTherapeutic Advances in Gastroenterology2020139
18The emerging role of miRNAs in inflammatory bowel disease: a reviewTherapeutic Advances in Gastroenterology2015136
19Treatment of alcoholic liver diseaseTherapeutic Advances in Gastroenterology2011131
20Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals?Therapeutic Advances in Gastroenterology2012130
21Nausea: a review of pathophysiology and therapeuticsTherapeutic Advances in Gastroenterology2016130
22The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trialTherapeutic Advances in Gastroenterology2009129
23A randomized trial of a fully covered self-expandable metallic stent versus plastic stents in anastomotic biliary strictures after liver transplantationTherapeutic Advances in Gastroenterology2014128
24Managing bile acid diarrhoeaTherapeutic Advances in Gastroenterology2010127
25The gut virome: the ‘missing link’ between gut bacteria and host immunity?Therapeutic Advances in Gastroenterology2019127
26Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trialTherapeutic Advances in Gastroenterology2013124
27Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitisTherapeutic Advances in Gastroenterology2016123
28Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease?Therapeutic Advances in Gastroenterology2013120
29Review: Treatment options for nonalcoholic fatty liver diseaseTherapeutic Advances in Gastroenterology2010119
30Advantages of enteral nutrition over parenteral nutritionTherapeutic Advances in Gastroenterology2013118
31Current, new and future biological agents on the horizon for the treatment of inflammatory bowel diseasesTherapeutic Advances in Gastroenterology2015115
32Eosinophilic colitis: epidemiology, clinical features, and current managementTherapeutic Advances in Gastroenterology2011114
33Surveillance for hepatocellular carcinoma: in whom and how?Therapeutic Advances in Gastroenterology2011111
34The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapyTherapeutic Advances in Gastroenterology2012109
35Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization studyTherapeutic Advances in Gastroenterology2016105
36Review: Functional dyspepsiaTherapeutic Advances in Gastroenterology2010104
37Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel diseaseTherapeutic Advances in Gastroenterology2011103
38Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trialsTherapeutic Advances in Gastroenterology2016100
39Optimal biliary access point and learning curve for endoscopic ultrasound-guided hepaticogastrostomy with transmural stentingTherapeutic Advances in Gastroenterology201799
40Review: Anti-adhesion molecule therapy for inflammatory bowel diseaseTherapeutic Advances in Gastroenterology201097
41Evaluation of regional and whole gut motility using the wireless motility capsule: relevance in clinical practiceTherapeutic Advances in Gastroenterology201297
42Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to dateTherapeutic Advances in Gastroenterology201896
43The controversial role of Enterococcus faecalis in colorectal cancerTherapeutic Advances in Gastroenterology201895
44Pain management in patients with inflammatory bowel disease: insights for the clinicianTherapeutic Advances in Gastroenterology201294
45Proton-pump inhibitors among adults: a nationwide drug-utilization studyTherapeutic Advances in Gastroenterology201892
46The changing landscape of hepatitis C virus therapy: focus on interferon-free treatmentTherapeutic Advances in Gastroenterology201590
47Automated endoscopic detection and classification of colorectal polyps using convolutional neural networksTherapeutic Advances in Gastroenterology202090
48Nutritional management of Crohn’s diseaseTherapeutic Advances in Gastroenterology201386
49Sofosbuvir, a NS5B polymerase inhibitor in the treatment of hepatitis C: a review of its clinical potentialTherapeutic Advances in Gastroenterology201485
50Screening for celiac disease in average-risk and high-risk populationsTherapeutic Advances in Gastroenterology201283